Cargando…

A computational method for drug repositioning using publicly available gene expression data

MOTIVATION: The identification of new therapeutic uses of existing drugs, or drug repositioning, offers the possibility of faster drug development, reduced risk, lesser cost and shorter paths to approval. The advent of high throughput microarray technology has enabled comprehensive monitoring of tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shabana, KM, Abdul Nazeer, KA, Pradhan, Meeta, Palakal, Mathew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674855/ https://www.ncbi.nlm.nih.gov/pubmed/26679199 http://dx.doi.org/10.1186/1471-2105-16-S17-S5

Ejemplares similares

Elucidating gene signatures that control the circadian rhythm in cyanobacteria using bioinformatics methods
por: Nandu, Tulip, et al.
Publicado: (2012)

A systems biology approach to the global analysis of transcription factors in colorectal cancer
por: Pradhan, Meeta P, et al.
Publicado: (2012)

Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma
por: Pradhan, Meeta P, et al.
Publicado: (2013)

Cliques for the identification of gene signatures for colorectal cancer across population
por: Pradhan, Meeta P, et al.
Publicado: (2012)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

Changing Trends in Computational Drug Repositioning
por: Yella, Jaswanth K., et al.
Publicado: (2018)

A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
por: Lee, Soo Youn, et al.
Publicado: (2020)

Computational drug repositioning of atorvastatin for ulcerative colitis
por: Bai, Lawrence, et al.
Publicado: (2021)

A computational drug repositioning method applied to rare diseases: Adrenocortical carcinoma
por: Lotfi Shahreza, Maryam, et al.
Publicado: (2020)

DrugSig: A resource for computational drug repositioning utilizing gene expression signatures
por: Wu, Hongyu, et al.
Publicado: (2017)

Computational drug repositioning through heterogeneous network clustering
por: Wu, Chao, et al.
Publicado: (2013)

A review of validation strategies for computational drug repositioning
por: Brown, Adam S, et al.
Publicado: (2016)

Hybrid attentional memory network for computational drug repositioning
por: He, Jieyue, et al.
Publicado: (2020)

Connecting genetics and gene expression data for target prioritisation and drug repositioning
por: Ferrero, Enrico, et al.
Publicado: (2018)

Drug repositioning for idiopathic epilepsy using gene expression signature data
por: Kumar, Pawan, et al.
Publicado: (2022)

Network-Based Inference Methods for Drug Repositioning
por: Chen, Hailin, et al.
Publicado: (2015)

Pathway Analysis for Drug Repositioning Based on Public Database Mining
por: Pan, Yongmei, et al.
Publicado: (2014)

Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease
por: Zhao, Mengnan, et al.
Publicado: (2018)

ksRepo: a generalized platform for computational drug repositioning
por: Brown, Adam S., et al.
Publicado: (2016)

Additional Neural Matrix Factorization model for computational drug repositioning
por: Yang, Xinxing, et al.
Publicado: (2019)

System and network biology-based computational approaches for drug repositioning
por: Pandita, Vasundhara, et al.
Publicado: (2022)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Transcriptional data: a new gateway to drug repositioning?
por: Iorio, Francesco, et al.
Publicado: (2013)

Drug Repositioning for Diabetes Based on 'Omics' Data Mining
por: Zhang, Ming, et al.
Publicado: (2015)

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning
por: Kim, Yoonbee, et al.
Publicado: (2022)

RETRACTED ARTICLE: Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles
por: Kim, In-Wha, et al.
Publicado: (2019)

Retraction Note: Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles
por: Kim, In-Wha, et al.
Publicado: (2022)

Large-scale computational drug repositioning to find treatments for rare diseases
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2018)

Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer
por: Rabben, Hanne-Line, et al.
Publicado: (2021)

A computational multi-targeting approach for drug repositioning for psoriasis treatment
por: Ibezim, Akachukwu, et al.
Publicado: (2021)

Repositioning Drugs for Rare Diseases Based on Biological Features and Computational Approaches
por: Otero-Carrasco, Belén, et al.
Publicado: (2022)

MNBDR: A Module Network Based Method for Drug Repositioning
por: Chen, He-Gang, et al.
Publicado: (2020)

Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction
por: Coelho, Edgar D., et al.
Publicado: (2016)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_82ndmndkbv8nsl5jok0ieo65am